Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hipBAGGER, Y. Z; TANKO, L. B; ALEXANDERSEN, P et al.Journal of internal medicine. 2006, Vol 259, Num 6, pp 598-605, issn 0954-6820, 8 p.Article

Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women : A randomized studyALEXANDERSEN, P; RIIS, B. J; CHRISTIANSEN, C et al.The Journal of clinical endocrinology and metabolism. 1999, Vol 84, Num 9, pp 3013-3020, issn 0021-972XArticle

Bone densitometry : A new, highly responsive region of interest in the distal forearm to monitor the effect of osteoporosis treatmentRAVN, P; ALEXANDERSEN, P; MØLLGAARD, A et al.Osteoporosis international. 1999, Vol 9, Num 4, pp 277-283, issn 0937-941XConference Paper

Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women : effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effectsALEXANDERSEN, P; BYRJALSEN, I; CHRISTIANSEN, C et al.British journal of obstetrics and gynaecology (Print). 2000, Vol 107, Num 3, pp 356-364, issn 0306-5456Article

The relationship of natural androgens to coronary heart disease in males : a reviewALEXANDERSEN, P; HAARBO, J; CHRISTIANSEN, C et al.Atherosclerosis. 1996, Vol 125, Num 1, pp 1-14, issn 0021-9150, 13 p.Article

The effect of menopause and hormone replacement therapy on bone alkaline phosphataseALEXANDERSEN, P; HASSAGER, C; RIIS, B. J et al.Scandinavian journal of clinical & laboratory investigation. 1995, Vol 55, Num 7, pp 571-576, issn 0036-5513Article

Number of years since menopause: Spontaneous bone loss is dependent but response to hormone replacement therapy is independentBJARNASON, N. H; ALEXANDERSEN, P; CHRISTIANSEN, C et al.Bone (New York, NY). 2002, Vol 30, Num 4, pp 637-642, issn 8756-3282Article

Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitisSKJØT-ARKIL, H; SCHETT, G; CHRISTIANSEN, C et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 3, pp 371-379, issn 0392-856X, 9 p.Article

Norethindrone acetate enhances the antiatherogenic effect of 17β-estradiol: A secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbitsALEXANDERSEN, P; HAARBO, J; SANDHOLDT, I et al.Arteriosclerosis, thrombosis, and vascular biology. 1998, Vol 18, Num 6, pp 902-907, issn 1079-5642Article

Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptidesCHRISTGAU, S; ROSENQUIST, C; ALEXANDERSEN, P et al.Clinical chemistry (Baltimore, Md.). 1998, Vol 44, Num 11, pp 2290-2300, issn 0009-9147Article

An update on biomarkers of bone turnover and their utility in biomedical research and clinical practiceLEEMING, D. J; ALEXANDERSEN, P; KARSDAL, M. A et al.European journal of clinical pharmacology. 2006, Vol 62, Num 10, pp 781-792, issn 0031-6970, 12 p.Article

Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapyALEXANDERSEN, P; RIIS, B. J; STAKKESTAD, J. A et al.The Journal of clinical endocrinology and metabolism. 2001, Vol 86, Num 2, pp 755-760, issn 0021-972XArticle

Circadian variation in bone resorption is not related to serum cortisolSCHLEMMER, A; HASSAGER, C; ALEXANDERSEN, P et al.Bone (New York, NY). 1997, Vol 21, Num 1, pp 83-88, issn 8756-3282Article

Evaluation of a new commercial IRMA for bone-specific alkaline phosphatase during treatment with hormone replacement therapy and calcitoninOVERGAARD, K; ALEXANDERSEN, P; RIIS, B. J et al.Clinical chemistry (Baltimore, Md.). 1996, Vol 42, Num 6, pp 973-974, issn 0009-9147, 1Article